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Introduction: There has been a global epidemic of COVID-19 caused by a novel coronavirus (SARS-2). Current 
research aims to study the demographic, clinical characteristics and co-morbidities in COVID-19 related deaths. 
Materials and Methods: This observational (descriptive) study was conducted at BBH Rawalpindi based on data 
from 1st March-15th June 2020 after ethical approval. Inclusion criteria were the deceased COVID PCR positive 
cases (>18 years of age) of both genders. Exclusion criteria were negative PCR, doubtful diagnosis and expiry 
outside the hospital setting. Data were collected from hospital records and family members. Demographic details, 
symptoms, duration of hospital stay, co-morbidities, type of ventilatory support were documented. Data analysed 
by SPSS, significant p<0.05. 
Results: There were 54 expiries from1st March to 13th June, 42(78%) males & 12(22%) females. The mean age was 
54.24+12.78 years. 76% had various comorbidities, i.e., diabetes (57%), hypertension (54%), ischemic heart disease 
(20%); stroke, cancer, COPD and hypothyroidism (<10% each). The most frequent cause of death was acute 
respiratory distress syndrome due to COVID-19. Two patients died of sepsis and multiorgan failure. 64% of 
patients received mechanical ventilation and 35% oxygen via non-rebreather masks. There was an average of 4 
days on the invasive mechanical ventilator. 51-60 years had the longest duration of illness and hospitalization till 
death, while 20-30 years had the shortest.  The average mortality climbed up (25% to 57%) from April to May 
2020. 
Conclusion: COVID-19 claims significant mortality. The risk factors for mortality being age above 50 years, male 
gender, co-morbidities like diabetes, hypertension, ischemic heart disease, need for mechanical ventilation upon 
admission and longer duration of illness. There is a need to intensify the vaccination and prevention in the 
community keeping in mind these high-risk groups. The high-risk cases, need to be aggressively managed to 
reduced mortality and improve outcomes.  
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Introduction 
 
Coronavirus disease 2019 (COVID-19) is caused by the 
SARS-Cov-2 virus, a highly infectious disease that was 
first reported in Wuhan city of China in December 
2019.1 Statistics show that till October 2020, approx. 36 
million cases had been reported globally with 
>10,00,000 deaths.2 The figures are still rising despite 
social distancing and preventive measures. Pakistan is 
facing the COVID-19 Pandemic just like the rest of the 
world. Since the population dynamics of Pakistan are 
considerably different than that of the western world, 
it is essential to understand the features that are 
unique to the Pakistani patients who have died due to 
the COVID-19 infection.  
COVID-19 presents with a wide spectrum of 
symptoms, patients being asymptomatic to having life-
threatening acute respiratory distress syndrome 
(ARDS). The COVID-19 has led to multiple causalities 
worldwide. It has been observed that the Intensive 
care unit (ICU) patients were more likely to have 
comorbidities, in comparison to non-ICU patients, 
including diabetes (35.4% vs. 20.3%) and 
hypertension.3 Lack of collated health care systems like 
the ‘National Health Services’ of the United Kingdom 
and as in other western countries have added to the 
paucity of accurate clinical data available regarding 
the patient-specific traits & the severity of infection in 
the region. 
A review article by Tian et al concluded that COVID-
19 patients with hypertension, diabetes, ischemic heart 
disease, cardiometabolic disorders and end-organ 
damage were at high risk of mortality.4 A Saudi study 
found a high prevalence of diabetes amongst admitted 
COVID-19 patients, also there was high mortality 
associated with poor diabetic control, geriatrics, lung 
involvement, severe deficiency of vitamin D and renal 
impairment.5 
There has been limited data available addressing 
COVID. The short term research is available regarding 
the symptomatology, diagnosis, management and 
mortality of COVID-19. However, results from long-
term studies are yet awaited. Worldwide observational 
studies and case series are being published to 
highlight the characteristics of deceased patients in 
China6,7 and other countries. This study aims to 
highlight COVID-19 patient characteristics at a local 
hospital in Pakistan. The identified risk factors 
according to data from the current study can be 
implemented in the screening of COVID cases, hence 
identifying high-risk cases that can be investigated and 
managed for a better outcome in terms of mortality as 
well as morbidity.8 
 
Materials and Methods 
 
This observational (descriptive) study was conducted 
at Benazir Bhutto Hospital Rawalpindi i.e. one of the 
busiest Public sector hospitals. The research proposal 
was approved by the Benazir Bhutto Hospital’s 
Institutional ethical committee. The duration of data 
collection was from 1st of March to 15th June 2020. 
Consent was obtained from the blood relations of the 
deceased.  
Inclusion criteria: The deceased COVID PCR positive 
cases were included by consecutive sampling. Adult 
cases > 18 years of age of both genders were included. 
Exclusion criteria: The cases with negative PCR or 
doubtful diagnosis weren’t included. Also, the cases 
whose families didn’t give consent were excluded. 
Cases the expired after being shifted out or discharged 
from the hospital were also excluded. The data was 
collected from hospital records and also from an 
interview with a family member. Demographic details, 
age, gender, duration and types of symptoms were 
inquired. The duration of the hospital stay was 
documented. Previous co-morbidities were inquired.  
A specially designed proforma was used to document 
data. All the cases received antibiotics, steroids and 
fluids during admission according to the hospital 
treatment protocol for COVID-19 infection. As per 
indication, patients were administered invasive 
mechanical ventilation or Oxygen via a non-
rebreathing mask. The hospital didn’t have any non-
invasive ventilation equipment during this time 
period.   
Data were analysed by SPSS version 26. Frequency 
and percentage calculated for qualitative variables 
(i.e., gender, type of symptom, co-morbidities, etc), 
mean and standard deviation calculated for 
quantitative variables (i.e., age, duration of symptoms, 
duration of hospital stay, etc.). The association of 
various variables (i.e., gender, age, co-morbidities, 
duration of symptoms) with mechanical ventilation 
was assessed by Chi-square test with significant 
p<0.05. Data is presented in the form of tables, pie 




Data of 54 cases were collected that expired in BBH 
from 1st March to 13th June. 42 (78%) males expired as 
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compared to 12 (22%) females. The mean age was 
54.24+12.78 years (20-77 years). The age group greatly 
affected was in the range 51-60 years (Figure 2). 13 
(24%) of patients died without any chronic disease. 41 
(76%) patients had various co-morbidities. Amongst 
these, Diabetes had the highest observed frequency in 
31 cases (57.4%), followed by Hypertension in 
29(53.7%). Other co-morbidities were ischemic heart 
disease 11 (20.4%). Stroke, cancer, chronic obstructive 
airway disease and hypothyroidism in < 10% (Figure 
3). All the cases had a history of respiratory symptoms 
upon hospital presentation. The main cause of death 
was acute respiratory distress syndrome due to 
COVID-19. Two patients out of the 54 died of sepsis 
and multiorgan failure. 
The mean duration of illness was 13+7.55 days (2-45). 
Mean hospital admission was 8+7.28 days (1-41). 
Duration of illness and hospitalization of age group 
51-60 years of age was the longest. This was 
approximately 16 days of illness and hospitalization of 
10 days before the mortality. The age range of 20-30 
years had the shortest duration of illness of 7 days and 
hospitalization of 2 days before death.  
Total 35 (64%) of patients received mechanical 
ventilation and 19(35.2%) of patients had maximum 
therapy of non-rebreather mask with 15 litres of 
oxygen (Figure 4). The mean duration of an invasive 
mechanical ventilator was about 2.89+6.05 days (1-41). 
The mortality climbed up significantly from 14 (25.9%) 
to 31 (57.4%) from April to May and then reduced to 9 
(16.7%) in June 2020. There was an association of 
mechanical ventilation with gender (p=0.027), 
however, mechanical ventilation wasn’t significantly 
associated with co-morbidities, duration of symptoms 
or age (p>0.05; Table 1). 
 
 
Table 1: Table representing the demographic variables and comorbidities in relation to mechanical ventilation 
in COVID related deaths (n=54) 





















Age (years) 54.24+12.78 53.4+12.8 55.7+12.9 0.517 
Diabetes 31 (57.4%) 21 (67.7%) 10 (32.3%) 0.601 
Hypertension 29 (53.7%) 18 (62%) 11 (37.9%) 0.649 
IHD 11 (20.4%) 6 (54.5%) 5 (45.5%) 0.424 
Carcinoma 01 (1.9%) 01 (2.9%) 0 (0%) 0.457 
CVA 03 (5.6%) 1 (33.3%) 02 (66.7%) 0.240 
Days of illness 13+7.55 14+8.15 11+6.14 0.224 
(Test of significance Chi-square, student t-test; significant p<0.05) 
 
 
Figure 1: The common presenting symptoms 
reported by COVID-19 patients (n=54) 
 
 
Figure 2: Bar graph representation of COVID cases 
that suffered mortality with respect to age groups 
and gender (n=54) 
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Figure 3: Bar graph presentation of Co-morbid 




Figure 4: Bar graph presentation of type of 




Figure 4: Bar graph presentation of average days of 
symptoms and the average hospital stay till mortality 




This data from the public sector hospital highlights 
that the males were much more affected by the 
severity of disease as compared to females. This might 
be due to the greater exposure of the male gender 
which point towards the social lifestyle difference or 
lack of equal access to the hospital in the female group. 
A meta-analysis by Bekham et al also reported that 
though there isn’t any difference in the proportion of 
males and females with confirmed COVID-19, 
however, males have three times the odds of requiring 
the intensive care unit (ICU) management.9 The 
previous coronavirus outbreaks (i.e., SARS-COV-1 and 
MERS) also have shown increases mortality among 
males.10,11 These gender-based differences are 
attributed to socioeconomic factors, the protective 
effect of oestradiol in females and differences in 
immune response between males and females.  
Regarding the age group, the maximum number of 
deaths was observed among cases between 40-70 years 
of age. There were eight expiries of less than forty 
years of age. This indicates that age > 40 years to be 
considered high risk for mortality. The data from 
Korea12 and Italy13 has demonstrated that > 80% of 
deaths have occurred in the elderly particularly above 
70 years of age. In our study, we observed maximum 
mortality in the age group 51-60 years. Hence, in our 
cases, middle-aged cases were also found to be at high 
risk of mortality in addition to the geriatric age group.  
Regarding the initial symptoms at presentation, fever 
was observed in approx. 80% cases followed by cough, 
shortness of breath and fatiguability. The fewer 
number of cases had neurological or abdominal 
symptoms. This data was from early 2020 when these 
symptoms were typically seen in COVID, however 
currently in 2021 newer strain of the COVID-19 virus 
has been identified that has atypical symptoms 
including abdominal pain, vomiting, rash and 
conjunctival congestion. This evolution of symptoms 
suggests that during an epidemic higher clinical 
suspicion is required to timely diagnose this highly 
infectious and lethal disease.  
Regarding co-morbidities, diabetes and hypertension 
were frequently observed in cases that suffered 
mortality. This may reflect the regional prevalence of 
diabetes and hypertension in the age group above 40 
years that was the most affected age group in this 
study. Also, we can infer that the presence of diabetes 
and hypertension in the COVID cases may be a risk 
factor for complications and mortality.  Hence, all 
COVID cases need to be screened for these co-
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morbidities for a better outcome. There were 24% of 
deaths without any pre-existing comorbidity. This 
indicates that even perfectly healthy cases are prone to 
complications and death. A study conducted by Paul 
Novosad et al14 compared the comorbidities associated 
risk of mortality between the UK and India and found 
that the COVID-19 health risk factors (i.e., diabetes, 
hypertension, chronic respiratory diseases, obesity, 
cancer and chronic heart diseases) are not expected to 
have a major effect on mortality or its age distribution. 
The invasive mechanical ventilation was administered 
in 64% of cases and most of these cases were male 
patients. Most of the female patients received the 
oxygen via a non-rebreather mask. There was a strong 
association of the male gender with the need for 
mechanical ventilatory support. There could be certain 
explanations for this. e.g., males being more severely 
affected by COVID-19 because of more outdoor 
exposure and social reasons in our country. We didn’t 
have a record of the history of smoking in our patients, 
but regional data show a higher prevalence of smoking 
among males as compared to females that could be the 
contributory factor for the need for ventilatory 
support. Research data shows 56% mortality in 
patients requiring invasive mechanical in ICU.15 
Pakistan is a developing country and the COVID-19 
pandemic has greatly affected an overstretched- 
overcrowded low resourced public hospital that has 
been thriving on the edge in normal circumstances. 
Lack of resources like Non-invasive ventilatory 
machines and limited ventilators were one of the 
major challenges faced by the COVID team. 35% of the 
deaths were observed in cases that were given 15 litres 
of oxygen via a non-rebreather mask as maximum 
support. Certain COVID cases deteriorated suddenly 
and the last-minute intubation and ventilation couldn’t 
revive them. Also, despite the utilization of all possible 
resources and efforts, there was high mortality. This 
points towards the need to upgrade the human 
resource as well as equipment quantitatively as well as 
qualitatively for better outcomes. During Pandemic 
Pakistan is facing an economic crisis and in view of the 
fragile health care system and limited resources of 
critical care, a coordinated and directed plan of action 
is required.16 
Another interesting analysis on the duration of illness 
and duration of hospitalization was done to see the 
average time period of illness in which patients came 
to the hospital and the resources required in terms of 
the number of days of hospitalization. There was a 
delay in presentation of the younger age group as 
reflected by the shorter duration of stay in the hospital 
before dying. Lack of proper pre-hospital care and 
sensitization to the seriousness of Pandemic might be a 
few factors of people not presenting earlier to the 
hospital. The older group had a greater number of 
hospitalization days comparatively which gives a clue 
to maximize resources for the coming months of the 
ongoing pandemic.  
There hasn’t been sufficient time since the onset of this 
epidemic to understand this highly contagious and 
lethal virus. The guidelines for COVID are yet in 
evolution and may take several years. The study had 
multiple limitations like the data did not include the 
patients who died in the Emergency Department who 
were hospitalized but awaiting beds for shifting. The 
patients included in this study were only the ones with 
COVID-19 positive swabs on PCR which has a 
sensitivity of 60%. This implies that the actual 
mortality would be much higher than the one seen in 
this study. Secondly, the peak was yet to come, the 
cases were on the rise during the study and disease 
trends might differ in the later months. Despite all 
these limitations, the current study provides the 
regional mortality related data that can be helpful and 
serve as the guide for better risk assessment of COVID 




COVID-19 claims significantly high mortality. The risk 
factors for mortality being age above 50 years, male 
gender, co-morbidities like diabetes, hypertension, 
ischemic heart disease, need for mechanical ventilation 
upon admission and longer duration of illness. There 
is a need to intensify the vaccination and prevention in 
the community keeping in mind these high-risk 
groups. The high-risk cases need to be aggressively 
managed to reduced mortality and improve outcomes. 
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